STUDIES ON HYBRID ARTIFICIAL LIVERS IN POINTS OF THE TECHNOLOGY FOR ORGAN RECONSTRUCTION

混合型人工肝从器官重建技术角度的研究

基本信息

  • 批准号:
    04454307
  • 负责人:
  • 金额:
    $ 1.15万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1994
  • 项目状态:
    已结题

项目摘要

Artificial liver and liver transplantation are the only way to replace the deteriorated functions of the damaged livers. However, complete replacement of the original liver functions is not yet possible for artificial livers today, and liver transplantation faces severe scarcity of donor livers.Recently, artificial livers such as hemodialysis, hemoperfusion, and plasmapheresis have been used clinically to treat patients with liver failure, but the survival rate has not so improved. One of the reasons for this poor survival rate appears to be a lack of metabolic support capacity for the damaged livers. In this study, the development of a hybrid artificial liver was studied in points of the technology for organ reconstruction. Combination of hepatocytes and artificial materials has been attempted to reconstruct the metabolic functions of liver.1) Natural substrata such as biomatrix of the liver and collagen, and synthetic substrata such as lactose-carrying polystirene were examined in primary culture of isolated hepatocytes, and these were useful for coating artificial materials.2) Artificial materials such as dextran microcarriers and cellulose multiporous microcarriers were investigated of their availability for immobilizing hepatocytes in a hybrid artificial liver. Hepatocytes immobilized to these microcarriers showed better NH3 and fructose metabolism.It was therefore suggested that these substrata and carriers were useful for the development of hybrid artificial livers.
人工肝和肝移植是替代受损肝脏功能恶化的唯一途径。然而,目前人工肝还不能完全替代原有的肝功能,肝移植面临着供肝严重短缺的问题。近年来,临床上已采用血液透析、血液灌流、血浆置换等人工肝治疗肝功能衰竭患者,但存活率并没有提高。存活率低的原因之一似乎是受损肝脏缺乏代谢支持能力。本研究从器官重建技术的角度对复合型人工肝的研制进行了研究。肝细胞与人工材料的结合已被尝试用于重建肝脏的代谢功能。1)在分离的肝细胞的原代培养中检测天然基质如肝的生物基质和胶原,以及合成基质如乳糖载体聚苯乙烯,这些材料可用于涂覆人造材料。研究了葡聚糖微载体和纤维素多孔微载体等人工材料在复合型人工肝中固定肝细胞的可行性。这些微载体固定化的肝细胞具有较好的NH_3和果糖代谢能力,因此,这些微载体和基质可用于杂交型人工肝的研制。

项目成果

期刊论文数量(55)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shinichi Kasai: "Celulose microcarrier for high-density culture of hepatocytes." Transplant.Proc.24. 2933-2934 (1992)
Shinichi Kasai:“用于肝细胞高密度培养的纤维素微载体。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Kasai: "Rat hepatocytes on a multiporous cellulose microcarrier for a hybrid artificial liver" Artif.Organs Today. 3. 217-225 (1994)
S.Kasai:“用于混合人工肝的多孔纤维素微载体上的大鼠肝细胞”Artif.Organs Today。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
葛西 眞一: "Hybrid Artificial Liverの研究 ーセルロース系マイクロキャリアへの肝細胞接着動態ー" 人工臓器. 21. 1055-1059 (1992)
Shinichi Kasai:“混合人工肝的研究 - 肝细胞粘附到纤维素微载体的动力学”人工器官。 21. 1055-1059 (1992)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shinichi Kasai: "Is the biological artificial liver clinically applicable?" Artifical Organs. 18. 348-354 (1994)
葛西新一:“生物人工肝临床适用吗?”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shinichi Kasai: "Beneficial effect of hepatocyte transplantation on hepatic failure." Transplant.Proc.24. 2990-2992 (1992)
Shinichi Kasai:“肝细胞移植对肝衰竭的有益作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KASAI Shinichi其他文献

KASAI Shinichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KASAI Shinichi', 18)}}的其他基金

A study of prehomogeneous vector spaces
预齐次向量空间的研究
  • 批准号:
    13640027
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Artificial liver support based on the regenerative medicine
基于再生医学的人工肝支持
  • 批准号:
    12470233
  • 财政年份:
    2000
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CROSS TALK BETWEEN BIOLOGICAL TRIPLET SYSTEMS (NEURO-ENDCRINE-IMMUNE) DURING LIVER REGENERATION
肝脏再生过程中生物三联体系统(神经内分泌免疫)之间的交互作用
  • 批准号:
    07407030
  • 财政年份:
    1995
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Studies of hepatic reconstruction for metabolic liver support.
用于代谢性肝脏支持的肝脏重建研究。
  • 批准号:
    02670530
  • 财政年份:
    1990
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Studies on Biomimetic Artificial Liver
仿生人工肝的研究
  • 批准号:
    63570585
  • 财政年份:
    1988
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Pathophysiological studies of hypofibronectineamia and superoxide radical in multiple organ failure (MOF)
多器官衰竭(MOF)中低纤维连接血症和超氧自由基的病理生理学研究
  • 批准号:
    61570599
  • 财政年份:
    1986
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Metabolic syndrome impairs oligodendrocyte metabolic support of neurons leading to Alzheimer’s disease/Alzheimer’s disease and related dementias
代谢综合征损害神经元的少突胶质细胞代谢支持,导致阿尔茨海默病/阿尔茨海默病和相关痴呆症
  • 批准号:
    10641057
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Metabolic activity in and metabolic support of malperfused brain tissue.
灌注不良脑组织的代谢活动和代谢支持。
  • 批准号:
    2391799
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Studentship
Panglial coupling and the metabolic support of axons and synapses
神经胶质细胞耦合以及轴突和突触的代谢支持
  • 批准号:
    235153551
  • 财政年份:
    2013
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Research Grants
A Solution to the Kidney Shortage: Exsanguineous Metabolic Support, From Breadbo
肾脏短缺的解决方案:来自 Breadbo 的无血代谢支持
  • 批准号:
    7928024
  • 财政年份:
    2010
  • 资助金额:
    $ 1.15万
  • 项目类别:
Protection of the Senescent Heart with Metabolic Support
通过代谢支持保护衰老心脏
  • 批准号:
    6605748
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Protection of the Senescent Heart with Metabolic Support
通过代谢支持保护衰老心脏
  • 批准号:
    6552845
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Protection of the Senescent Heart with Metabolic Support
通过代谢支持保护衰老心脏
  • 批准号:
    6509369
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Protection of the Senescent Heart with Metabolic Support
通过代谢支持保护衰老心脏
  • 批准号:
    6326607
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Protection of the Senescent Heart with Metabolic Support
通过代谢支持保护衰老心脏
  • 批准号:
    6763182
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Protection of the Senescent Heart with Metabolic Support
通过代谢支持保护衰老心脏
  • 批准号:
    6916480
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了